Table 1.
Demographic, clinical, and laboratory characteristics of the study population.
| VARIABLE | N (%) or MEAN ± SD |
|---|---|
| Age (years) | 60.3 ± 13.5 |
| Age categories | |
| <30 years | 5 (2 %) |
| 30–44 years | 41 (12 %) |
| 45–59 years | 109 (31 %) |
| 60–74 years | 134 (38 %) |
| ≥75 years | 61 (17 %) |
| Sex | |
| Male | 194 (55.4 %) |
| Female | 156 (44.6 %) |
| Risk Factors | |
| Diabetes | 103 (29.4 %) |
| Hypertension | 182 (52.0 %) |
| Dyslipidaemia | 142 (40.6 %) |
| Chronic kidney disease | 95 (27.1 %) |
| Coronary artery disease | 141 (40.3 %) |
| Smoking | 168 (48.0 %) |
| Previous Heart failure | 219 (62.6 %) |
| Atrial fibrillation | 101 (29.1 %) |
| Etiology | |
| PPCM | 11 (3.1 %) |
| CMP (systemic) | 64 (18.3 %) |
| CHD | 22 (6.3 %) |
| HCM | 10 (2.9 %) |
| RHD | 52 (14.9 %) |
| CMP (idiopathic) | 35 (10.0 %) |
| Ischemic | 140 (40.0 %) |
| Others | 16 (4.6 %) |
| SBP (mmHg) | 113 ± 28.54 |
| SBP <100 | 176 (50.3 %) |
| SBP 100-140 | 124 (35.4 %) |
| SBP >140 | 50 (14.3 %) |
| Serum creatinine (mg/dL) | 1.42 ± 0.908 |
| Serum sodium (mEq/L) | 139.7 ± 4.24 |
| Serum potassium (mEq/L) | 4.31 ± 0.61 |
| Hemoglobin (gm/dl) | 11.7 ± 2.26 |
| LVEF (%) | 41.72 ± 12.31 |
| LVEF <40 | 198 (56.6 %) |
| LVEF 40-50 | 72 (20.6 %) |
| LVEF >50 | 80 (22.8 %) |
| hsTropI at admission (ng/L) | 59.38 ± 80.63 |
| hsTropI at discharge (ng/L) | 40.14 ± 42.50 |
| Length of hospitalization (days) | 7.2 ± 4.01 |
Abbreviations: PPCM-Peripartum cardiomyopathy; CMP-Cardiomyopathy; CHD-Congenital heart disease; HCM-Hypertrophic cardiomyopathy; RHD-Rheumatic heart disease; SBP-Systolic blood pressure; LVEF-Left ventricular ejection fraction.